182 related articles for article (PubMed ID: 28166380)
41. Automated Glycan Assembly of
Fittolani G; Shanina E; Guberman M; Seeberger PH; Rademacher C; Delbianco M
Angew Chem Int Ed Engl; 2021 Jun; 60(24):13302-13309. PubMed ID: 33784430
[TBL] [Abstract][Full Text] [Related]
42. Restricted HIV-1 Env glycan engagement by lectin-reengineered DAVEI protein chimera is sufficient for lytic inactivation of the virus.
Parajuli B; Acharya K; Bach HC; Parajuli B; Zhang S; Smith AB; Abrams CF; Chaiken I
Biochem J; 2018 Mar; 475(5):931-957. PubMed ID: 29343613
[TBL] [Abstract][Full Text] [Related]
43. Saturation transfer difference (STD) NMR spectroscopy characterization of dual binding mode of a mannose disaccharide to DC-SIGN.
Angulo J; Díaz I; Reina JJ; Tabarani G; Fieschi F; Rojo J; Nieto PM
Chembiochem; 2008 Sep; 9(14):2225-7. PubMed ID: 18720494
[No Abstract] [Full Text] [Related]
44. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells.
Arrighi JF; Pion M; Wiznerowicz M; Geijtenbeek TB; Garcia E; Abraham S; Leuba F; Dutoit V; Ducrey-Rundquist O; van Kooyk Y; Trono D; Piguet V
J Virol; 2004 Oct; 78(20):10848-55. PubMed ID: 15452205
[TBL] [Abstract][Full Text] [Related]
45. Identification of the DC-SIGN-interactive domains on the envelope glycoprotein of HIV-1 CRF07_BC.
Liao CF; Wang SF; Lin YT; Ho DD; Chen YM
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):831-9. PubMed ID: 21142800
[TBL] [Abstract][Full Text] [Related]
46. STD NMR and molecular modelling insights into interaction of novel mannose-based ligands with DC-SIGN.
Kotar A; Tomašič T; Lenarčič Živković M; Jug G; Plavec J; Anderluh M
Org Biomol Chem; 2016 Jan; 14(3):862-75. PubMed ID: 26580315
[TBL] [Abstract][Full Text] [Related]
47. Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN.
Martínez-Avila O; Hijazi K; Marradi M; Clavel C; Campion C; Kelly C; Penadés S
Chemistry; 2009 Sep; 15(38):9874-88. PubMed ID: 19681073
[TBL] [Abstract][Full Text] [Related]
48. Frontal affinity chromatography analysis of constructs of DC-SIGN, DC-SIGNR and LSECtin extend evidence for affinity to agalactosylated N-glycans.
Yabe R; Tateno H; Hirabayashi J
FEBS J; 2010 Oct; 277(19):4010-26. PubMed ID: 20840590
[TBL] [Abstract][Full Text] [Related]
49. Insights into molecular recognition of Lewis(X) mimics by DC-SIGN using NMR and molecular modelling.
Guzzi C; Angulo J; Doro F; Reina JJ; Thépaut M; Fieschi F; Bernardi A; Rojo J; Nieto PM
Org Biomol Chem; 2011 Oct; 9(22):7705-12. PubMed ID: 21984435
[TBL] [Abstract][Full Text] [Related]
50. DC-SIGN increases the affinity of HIV-1 envelope glycoprotein interaction with CD4.
Hijazi K; Wang Y; Scala C; Jeffs S; Longstaff C; Stieh D; Haggarty B; Vanham G; Schols D; Balzarini J; Jones IM; Hoxie J; Shattock R; Kelly CG
PLoS One; 2011; 6(12):e28307. PubMed ID: 22163292
[TBL] [Abstract][Full Text] [Related]
51. C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles.
Lozach PY; Amara A; Bartosch B; Virelizier JL; Arenzana-Seisdedos F; Cosset FL; Altmeyer R
J Biol Chem; 2004 Jul; 279(31):32035-45. PubMed ID: 15166245
[TBL] [Abstract][Full Text] [Related]
52. DCIR interacts with ligands from both endogenous and pathogenic origin.
Bloem K; Vuist IM; van den Berk M; Klaver EJ; van Die I; Knippels LM; Garssen J; García-Vallejo JJ; van Vliet SJ; van Kooyk Y
Immunol Lett; 2014; 158(1-2):33-41. PubMed ID: 24239607
[TBL] [Abstract][Full Text] [Related]
53. Bifunctional CD4-DC-SIGN fusion proteins demonstrate enhanced avidity to gp120 and inhibit HIV-1 infection and dissemination.
Du T; Hu K; Yang J; Jin J; Li C; Stieh D; Griffin GE; Shattock RJ; Hu Q
Antimicrob Agents Chemother; 2012 Sep; 56(9):4640-9. PubMed ID: 22687513
[TBL] [Abstract][Full Text] [Related]
54. Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN.
Wang SK; Liang PH; Astronomo RD; Hsu TL; Hsieh SL; Burton DR; Wong CH
Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3690-5. PubMed ID: 18310320
[TBL] [Abstract][Full Text] [Related]
55. DC-SIGN binds to HIV-1 glycoprotein 120 in a distinct but overlapping fashion compared with ICAM-2 and ICAM-3.
Su SV; Hong P; Baik S; Negrete OA; Gurney KB; Lee B
J Biol Chem; 2004 Apr; 279(18):19122-32. PubMed ID: 14970226
[TBL] [Abstract][Full Text] [Related]
56. Identification of a glycan cluster in gp120 essential for irreversible HIV-1 lytic inactivation by a lectin-based recombinantly engineered protein conjugate.
Parajuli B; Acharya K; Nangarlia A; Zhang S; Parajuli B; Dick A; Ngo B; Abrams CF; Chaiken I
Biochem J; 2020 Nov; 477(21):4263-4280. PubMed ID: 33057580
[TBL] [Abstract][Full Text] [Related]
57. Multiple modes of binding enhance the affinity of DC-SIGN for high mannose N-linked glycans found on viral glycoproteins.
Feinberg H; Castelli R; Drickamer K; Seeberger PH; Weis WI
J Biol Chem; 2007 Feb; 282(6):4202-9. PubMed ID: 17150970
[TBL] [Abstract][Full Text] [Related]
58. Epitope mapping on the dendritic cell-specific ICAM-3-grabbing non-integrin (DC-SIGN) pathogen-attachment factor.
Sierra-Filardi E; Estecha A; Samaniego R; Fernández-Ruiz E; Colmenares M; Sánchez-Mateos P; Steinman RM; Granelli-Piperno A; Corbí AL
Mol Immunol; 2010 Jan; 47(4):840-8. PubMed ID: 19879650
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of HIV entry by carbohydrate-binding proteins.
Balzarini J
Antiviral Res; 2006 Sep; 71(2-3):237-47. PubMed ID: 16569440
[TBL] [Abstract][Full Text] [Related]
60. A Remote Secondary Binding Pocket Promotes Heteromultivalent Targeting of DC-SIGN.
Wawrzinek R; Wamhoff EC; Lefebre J; Rentzsch M; Bachem G; Domeniconi G; Schulze J; Fuchsberger FF; Zhang H; Modenutti C; Schnirch L; Marti MA; Schwardt O; Bräutigam M; Guberman M; Hauck D; Seeberger PH; Seitz O; Titz A; Ernst B; Rademacher C
J Am Chem Soc; 2021 Nov; 143(45):18977-18988. PubMed ID: 34748320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
